Also Known As: Moexipril, Univasc, Perdix

Moexipril (marketed under the tradenames Univasc and Perdix) is an ACE inhibitor. Moexipril hydrochloride is a potent orally active non-sulfhydryl angiotensin converting enzyme inhibitor (ACE)[1] which is used for the treatment of hypertension and congestive heart failure. Moexipril can be administered alone or together with other antihypertensives or diuretics[2]. It works by inhibiting the conversion of angiotensin I to angiotensin II[3]. Moexipril is available from Schwarz'Pharma under the trade name Univasc [3][4].

Print this Page

All Treatments

Average Effectiveness

This is the Average effectiveness per ailment as reported by our participants (you).

  • 0 = No improvement or Worse
  • 1 = Slight improvement
  • 2 = Moderate Improvement
  • 3 = Significant Improvement
  • 4 = Cured

Order By

Type of Treatment

Date Range

Minimum Number of Users

Complete a survey on Moexipril to help the CureCrowd community

If you have tried to treat this ailment, please complete the following form to help us better our data, and help guide people to the best possible treatments. CureCrowd is a public resource with absolutely no vested interest in the outcomes of our studies.